Hila Magen
- Spécialisation: Hematologist
- 35 années d'expérience
- Parle:English, Hebrew
- Consultations en ligne : disponibles
- Espace de travail: Israël, Ramat Gan, Centre médical Sheba
- Heads a Multiple Myeloma & Amyloidosis unit; 100+ scientific publications; principal investigator for point-of-care CAR-T programs.
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Consultation en ligne avec Hila Magen
Services du médecin
- Chimiothérapie
- Thérapie CAR T
- Chimiothérapie du lymphome
- Chimiothérapie contre la leucémie
- Аphérèse thérapeutique
- Une greffe de moelle osseuse
- Transplantation de cellules souches haploidentiques
- Transplantation allogénique de moelle osseuse d'un donneur apparenté
- Transplantation allogénique de moelle osseuse provenant d'un donneur non apparenté
- Plasmaphérèse
- Plasmaphérèse DFPP
- Ultrason
- CT (tomodensitométrie)
- Biopsie
- Test sanguin avec marqueur tumoral
- Immunohistochimie
- Biopsie de moelle osseuse
- Consultation en ligne avec un oncologue
Où en sommes-nous ?
Qualifications
Dr. Hila Magen, MD
Head, Multiple Myeloma & Amyloidosis Unit – Sheba Medical Center
Leading Expert in Multiple Myeloma, Amyloidosis & Advanced Cellular Therapies
Dr. Hila Magen is a distinguished hemato-oncologist with over 35 years of experience, recognized as one of Israel’s leading experts in the treatment of multiple myeloma and complex plasma cell disorders.
As Head of the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center, she leads a highly specialized program focused on advanced, personalized therapies, including CAR-T cell treatment for high-risk patients.
Areas of Expertise
- Multiple Myeloma (Primary Focus)
Comprehensive management of relapsed, refractory, and high-risk myeloma- Amyloidosis & Plasma Cell Disorders
Advanced diagnosis and tailored treatment strategies - Advanced Cellular Therapies
-
- CAR-T Cell Therapy – principal investigator in innovative, point-of-care CAR-T programs
- Integration of cutting-edge immunotherapies into clinical care
- Hematologic Malignancies
Lymphomas and complex blood disorders requiring precision treatment
Clinical Leadership & Innovation
Dr. Magen leads one of the region’s most advanced units dedicated to myeloma and amyloidosis, focusing on:
- Personalized, targeted therapies
- Early access to innovative treatments and clinical trials
- Improving long-term outcomes and quality of life
She is actively involved in developing next-generation CAR-T therapies, offering patients access to some of the most advanced treatment options available worldwide.
International Training & Expertise
Dr. Magen completed advanced training at leading global institutions:
- Fellowship in Multiple Myeloma – University of Arkansas for Medical Sciences
- Fellowship in Lymphocytic Leukemia – MD Anderson Cancer Center
Leadership & Academic Roles
- Head, Multiple Myeloma & Amyloidosis Unit, Sheba Medical Center
- Instructor, Tel Aviv University
- Active contributor and speaker at international hematology conferences
Research & Recognition
- Author of 100+ scientific publications
- Contributor to landmark clinical studies in multiple myeloma treatment
- Active reviewer in international medical journals
Clinical Approach
Dr. Magen is known for delivering highly personalized and innovative care, focusing on:
- Precision diagnosis and tailored treatment plans
- Combining standard therapies with cutting-edge innovations
- Supporting patients through complex, long-term treatment journeys
Patient-Centered Care
Dr. Magen provides compassionate, expert care, helping patients navigate complex diagnoses with access to world-class treatments, advanced technologies, and multidisciplinary support.
A Leader in Modern Myeloma Treatment
Through her leadership in CAR-T therapy, precision medicine, and advanced myeloma care, Dr. Magen offers patients access to one of the most specialized and advanced treatment programs globally.
Vous pourriez aussi être intéressé
Paiement et récompenses
Vous ne payez pas pour nos services
Vous effectuez votre paiement directement à la clinique ou sur leur compte bancaire officiel.
Certaines cliniques peuvent exiger un acompte dans le cadre de leur politique.
Étalez vos paiements avec des options de versements.
Gagnez des récompenses en parrainant vos amis sur Bookimed.